Aclaris Therapeutics, Inc. SEC filings ACRS

Aclaris Therapeutics, Inc. has 872 filings in SEC EDGAR's recent list, going back to Sep 10, 2012. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Aclaris Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Material agreement
Oct 27, 2026 Oct 27, 2026
424B5 Prospectus supplement Oct 27, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 27, 2026 Oct 27, 2026
8-K Current report
Material agreement
Aug 6, 2026 Aug 6, 2026
S-3ASR Automatic shelf registration Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 4, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 28, 2026 Apr 28, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 4, 2026
8-K Current report
Regulation FD disclosure
Mar 11, 2026 Mar 10, 2026
8-K Current report
Regulation FD disclosure
Mar 10, 2026 Mar 9, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 6, 2026 Jan 6, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Regulation FD disclosure
Oct 14, 2025 Oct 14, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 29, 2025 Jul 29, 2025
8-K Current report
Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
S-8 Employee stock plan registration Jun 5, 2025 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 5, 2025 Jun 5, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 5, 2025
PRE 14A Preliminary proxy statement Apr 14, 2025 Jun 5, 2025
EFFECT Filing Mar 7, 2025 —
CORRESP Letter to the SEC Mar 5, 2025 —
UPLOAD Letter from the SEC Mar 4, 2025 —
S-3 Shelf registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
EFFECT Filing Dec 31, 2024 —
424B3 Prospectus Dec 31, 2024 —
CORRESP Letter to the SEC Dec 27, 2024 —
UPLOAD Letter from the SEC Dec 26, 2024 —
S-3 Shelf registration Dec 19, 2024 —
D Filing Dec 4, 2024 —
S-8 Employee stock plan registration Nov 27, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
Nov 18, 2024 Nov 16, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jul 16, 2024 Jul 16, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 6, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2024 May 7, 2024
S-8 Employee stock plan registration May 7, 2024 —
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 6, 2024
8-K Current report
Officer or director change
Mar 19, 2024 Mar 14, 2024
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
8-K/A Amended current report
Officer or director change
Feb 5, 2024 Jan 15, 2024
8-K Current report
Officer or director change
Feb 5, 2024 Jan 31, 2024
8-K Current report
Results of operations, Officer or director change
Jan 19, 2024 Jan 15, 2024
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Dec 19, 2023 Dec 19, 2023
8-K Current report
Regulation FD disclosure, Other events
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
8-K Current report
Regulation FD disclosure
Sep 18, 2023 Sep 18, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
8-K Current report
Officer or director change
Jun 12, 2023 Jun 9, 2023
8-K Current report
Shareholder vote results
Jun 2, 2023 Jun 1, 2023
8-K Current report
Material agreement
Jun 1, 2023 May 26, 2023
S-8 Employee stock plan registration May 8, 2023 —
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2023 May 8, 2023
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 —
ARS Annual report to shareholders Apr 20, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Apr 14, 2023 Apr 14, 2023
PRE 14A Preliminary proxy statement Apr 10, 2023 —
8-K Current report
Regulation FD disclosure
Mar 31, 2023 Mar 30, 2023
8-K Current report
Officer or director change
Mar 27, 2023 Mar 23, 2023
8-K Current report
Other events
Mar 6, 2023 Mar 6, 2023
8-K Current report
Material agreement, Agreement ended
Feb 23, 2023 Feb 23, 2023
424B5 Prospectus supplement Feb 23, 2023 —
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Officer or director change
Jan 6, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Dec 13, 2022 Dec 9, 2022
8-K Current report
Officer or director change
Nov 22, 2022 Nov 18, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 8, 2022 Nov 8, 2022
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Officer or director change
Aug 1, 2022 Aug 1, 2022
8-K Current report
Shareholder vote results
Jun 3, 2022 Jun 2, 2022
S-8 Employee stock plan registration May 10, 2022 —
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
DEFA14A Additional proxy material Apr 21, 2022 —
DEF 14A Proxy statement Apr 21, 2022 Jun 2, 2022
8-K Current report
Regulation FD disclosure
Apr 14, 2022 Apr 13, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Officer or director change
Jan 14, 2022 Jan 12, 2022
8-K Current report
Regulation FD disclosure
Dec 7, 2021 Dec 7, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Results of operations, Officer or director change
Nov 2, 2021 Nov 1, 2021
8-K Current report
Regulation FD disclosure
Aug 27, 2021 Aug 27, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Agreement ended
Jul 26, 2021 Jul 23, 2021
8-K Current report
Material agreement, Other events
Jun 11, 2021 Jun 8, 2021
424B5 Prospectus supplement Jun 10, 2021 —
424B5 Prospectus supplement Jun 8, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Jun 8, 2021 Jun 8, 2021
8-K Current report
Shareholder vote results
Jun 3, 2021 Jun 3, 2021
S-3ASR Automatic shelf registration May 20, 2021 —
8-K Current report
Material agreement
May 20, 2021 May 20, 2021
S-8 Employee stock plan registration May 7, 2021 —
10-Q Quarterly report May 7, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 7, 2021 May 7, 2021
DEFA14A Additional proxy material Apr 22, 2021 —
DEF 14A Proxy statement Apr 22, 2021 Jun 3, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Material agreement, Agreement ended, Other events
Jan 22, 2021 Jan 19, 2021
424B5 Prospectus supplement Jan 20, 2021 —
S-3MEF Filing Jan 20, 2021 —
424B5 Prospectus supplement Jan 19, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Jan 19, 2021 Jan 19, 2021
8-K Current report
Other events
Dec 15, 2020 Dec 15, 2020
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K Current report
Regulation FD disclosure
Sep 15, 2020 Sep 15, 2020
8-K Current report
Officer or director change
Aug 14, 2020 Aug 13, 2020
8-K Current report
Material agreement
Aug 13, 2020 Aug 13, 2020
424B5 Prospectus supplement Aug 13, 2020 —
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 7, 2020 Aug 7, 2020
8-K Current report
Bylaw or fiscal year change
Jun 24, 2020 Jun 23, 2020
8-K Current report
Regulation FD disclosure, Other events
Jun 17, 2020 Jun 17, 2020
8-K Current report
Shareholder vote results
Jun 4, 2020 Jun 4, 2020
8-K Current report
Regulation FD disclosure
May 27, 2020 May 27, 2020
8-K Current report
Regulation FD disclosure
May 15, 2020 May 15, 2020
S-8 Employee stock plan registration May 7, 2020 —
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
EFFECT Filing Apr 29, 2020 —
424B5 Prospectus supplement Apr 29, 2020 —
CORRESP Letter to the SEC Apr 23, 2020 —
DEFA14A Additional proxy material Apr 23, 2020 —
DEF 14A Proxy statement Apr 23, 2020 Jun 4, 2020
D Filing Apr 8, 2020 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Mar 31, 2020 Mar 30, 2020
UPLOAD Letter from the SEC Mar 19, 2020 —
S-3 Shelf registration Mar 13, 2020 —
8-K Current report
Material agreement
Mar 13, 2020 Mar 13, 2020
10-K Annual report Feb 25, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 25, 2020 Feb 25, 2020
8-K Current report
Regulation FD disclosure
Jan 13, 2020 Jan 13, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 8, 2020 Jan 7, 2020
8-K Current report
Regulation FD disclosure
Dec 3, 2019 Dec 2, 2019
8-K Current report
Regulation FD disclosure
Nov 21, 2019 Nov 21, 2019
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
8-K Current report
Material agreement
Oct 17, 2019 Oct 15, 2019
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
Oct 11, 2019 Oct 10, 2019
8-K Current report
Regulation FD disclosure
Sep 27, 2019 Sep 27, 2019
8-K Current report
Officer or director change
Sep 9, 2019 Sep 3, 2019
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Sep 5, 2019 Sep 3, 2019
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Regulation FD disclosure
Jul 30, 2019 Jul 30, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 3, 2019 Jul 2, 2019
8-K Current report
Regulation FD disclosure
Jun 17, 2019 Jun 17, 2019
8-K Current report
Officer or director change, Shareholder vote results
Jun 7, 2019 Jun 6, 2019
8-K Current report
Regulation FD disclosure
Jun 5, 2019 Jun 5, 2019
CT ORDER Filing May 9, 2019 —
10-Q Quarterly report May 8, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 8, 2019 May 8, 2019
DEFA14A Additional proxy material Apr 25, 2019 —
DEF 14A Proxy statement Apr 25, 2019 Jun 6, 2019
8-K Current report
Regulation FD disclosure
Apr 4, 2019 Apr 4, 2019
S-8 Employee stock plan registration Mar 29, 2019 —
10-K Annual report Mar 18, 2019 Dec 31, 2018
8-K Current report
Results of operations, Regulation FD disclosure
Mar 18, 2019 Mar 18, 2019
8-K Current report
Other events
Feb 8, 2019 Feb 8, 2019
8-K/A Amended current report Jan 18, 2019 Nov 30, 2018
8-K Current report
Officer or director change
Dec 20, 2018 Dec 17, 2018
CT ORDER Filing Dec 20, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ACRS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wayne, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1557746

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.